Summary : Torrent Pharmaceuticals, located in Ahmedabad, said on Thursday that it had agreed to buy four brands from Dr Reddy’s Laboratories…
Merger / Acquisition
-
-
Merger / Acquisition
Marksans Pharma acquires Access Healthcare for Medical Products L.L.C , Dubai for Rs 27 cr
by adminby adminSummary: Marksans Pharma signed a share purchase agreement to acquire a 100% stake in Access Healthcare for Medical Products L.L.C, a Dubai-based…
-
Merger / Acquisition
Advanz Pharma Signs Acquisition Agreement for Intercept Pharmaceuticals
by adminby adminSummary: UK-headquartered pharma company, Advanz Pharma, has announced in a May 5, 2022 press release that it has signed an agreement with…
-
Merger / Acquisition
Lilly Pumps $700M into Boston-Based RNA Therapeutics Facility
by adminby adminSummary: Eli Lilly and Company is investing $700 million to build a state-of-the-art facility in Boston’s seaport as part of plans to…
-
Bristol Myers SquibbCompaniesMerck & CoMerger / Acquisition
BMS and Merck Buy Big Into Amphista’s Protein Degradation Platform with 2.3 Billion Collab
by adminby adminSummary : Bristol Myers Squibb and Merck KGaA are diving deeper into the protein degradation pool, with both inking partnerships with Amphista Therapeutics…
-
Merger / AcquisitionPiramal Group
Piramal Pharma To Acquire Hemmo Pharma For Rs 775 Cr
by adminby adminSummary : Piramal Enterprises said in a regulatory filing on Wednesday that its subsidiary Piramal Pharma Ltd has signed into a deal…
-
Alembic PharmaMerger / Acquisition
Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
by adminby adminSummary : The company has acquired remaining 40 per cent stake from Orbicular Pharmaceutical Technologies, to have 100 per cent holding in…
-
CompaniesIndiaMerger / AcquisitionNovartis
Dr. Reddy’s will Pay Rs 463 Crore for Novartis’ Cardiovascular Drug Cidmus (Valsartan +Sacubitril)
by adminby adminSummary Dr Reddy’s Laboratories, an Indian generic pharmaceutical company, has agreed to pay $61 million to Novartis AG for the cardiovascular brand…
-
Amgen Inc.Merger / Acquisition
Amgen has bought Five Prime Therapeutics for $1.9 Billion
by adminby adminSummary : Five Prime’s lead asset, Bemarituzumab, is a first-in-class, Phase 3 ready anti-FGFR2b antibody with positive data from a randomized, placebo-controlled…
-
Merger / Acquisition
Halozyme has agreed to Acquire Antares Pharma for $960 million.
by adminby adminSummary : Halozyme Therapeutics has announced a formal agreement to acquire all of Antares Pharma’s outstanding shares in a deal worth about…